BioMarin to Attend Upcoming Investor Conference

SAN RAFAEL, Calif., May 31, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. BMRN, today announced that Dan Spiegelman, Executive Vice President and Chief Financial Officer, will participate in the Goldman Sachs 38th Annual Global Healthcare Conference on June 13, 2017 at 1:20pm PT/4:20pm ET, in Rancho Palos Verdes, California. To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following the event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biomarin-to-attend-upcoming-investor-conference-300465840.html

SOURCE BioMarin Pharmaceutical Inc.